Skip to content
Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges episode artwork

Jul 20, 2026 11 min

Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges

from Clinician's Roundtable

Host: Alexandria May, PharmD, BCPS Guest: David E. Griffith, MD Even as our understanding of nontuberculous mycobacterial (NTM) lung disease advances, major gaps remain, from defining meaningful treatment success to overcoming innate drug resistance. In this conversation with Dr. Alexandria May, Dr. David Griffith shares his perspective on how recent evidence is shaping treatment decisions for these patients and explains why significant unmet needs persist. Dr. Griffith is a Professor of Medicine in the Division of Mycobacterial and Respiratory Infections within the Department of Medicine at National Jewish Health in Denver.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges

0:00 11:00

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Clinician's Roundtable?

This episode is 11 minutes long.

When was this Clinician's Roundtable episode published?

This episode was published on July 20, 2026.

Can I download this Clinician's Roundtable episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.